Specifically, inhibition of BH4 synthesis in vivo reportedly abolishes T cell-mediated autoimmunity and allergic inflammation, whereas GCH1 overexpression increases BH4 levels, leading to increased responses by CD4- and CD8-expressing T cells and enhanced antitumor activity in vivo (48). The gene discussed is CD8A; the disease is Autoimmunity.